AvePoint (NASDAQ:AVPT) Research Coverage Started at BMO Capital Markets

BMO Capital Markets started coverage on shares of AvePoint (NASDAQ:AVPT – Free Report) in a research report released on Tuesday, Marketbeat reports. The firm issued an outperform rating and a $17.00 target price on the stock.

AVPT has been the topic of several other research reports. TD Cowen raised their price target on AvePoint from $14.00 to $15.00 and gave the company a “buy” rating in a report on Friday, August 7th. Wall Street Zen raised AvePoint from a “hold” rating to a “buy” rating in a report on Saturday, September 12th. Stephens upped their target price on shares of AvePoint from $16.00 to $17.00 and gave the company an “overweight” rating in a research report on Monday, September 21st. Scotiabank raised their target price on shares of AvePoint from $12.00 to $15.00 and gave the company a “sector outperform” rating in a research note on Friday, August 7th. Finally, Citigroup reissued a “neutral” rating on shares of AvePoint in a research note on Wednesday, August 12th. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, AvePoint has a consensus rating of “Moderate Buy” and a consensus target price of $16.41.

Get Our Latest Research Report on AVPT

AvePoint Stock Performance

NASDAQ:AVPT opened at $14.41 on Tuesday. The stock’s fifty day moving average price is $13.45 and its two-hundred day moving average price is $11.71. AvePoint has a 52-week low of $8.84 and a 52-week high of $15.48. The company has a market cap of $3.05 billion, a price-to-earnings ratio of 45.03 and a beta of 1.17.

AvePoint (NASDAQ:AVPT – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.08 by $0.04. The company had revenue of $124.50 million during the quarter, compared to analysts’ expectations of $121.38 million. AvePoint had a return on equity of 15.97% and a net margin of 15.33%. On average, equities analysts predict that AvePoint will post 0.25 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Brian Brown sold 28,894 shares of the company’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $15.15, for a total value of $437,744.10. Following the completion of the sale, the insider owned 335,710 shares in the company, valued at approximately $5,086,006.50. This represents a 7.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 128,894 shares of company stock valued at $1,825,241 in the last ninety days. Corporate insiders own 22.66% of the company’s stock.

Hedge Funds Weigh In On AvePoint

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP increased its stake in shares of AvePoint by 25.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,264,082 shares of the company’s stock valued at $31,040,000 after acquiring an additional 666,422 shares during the last quarter. Wellington Management Group LLP boosted its stake in AvePoint by 106.7% during the 2nd quarter. Wellington Management Group LLP now owns 2,776,579 shares of the company’s stock worth $31,125,000 after acquiring an additional 1,433,299 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in AvePoint by 25.0% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,675,587 shares of the company’s stock valued at $25,445,000 after purchasing an additional 535,015 shares during the period. Renaissance Technologies LLC grew its holdings in AvePoint by 16.4% during the first quarter. Renaissance Technologies LLC now owns 2,580,153 shares of the company’s stock valued at $24,537,000 after purchasing an additional 363,200 shares during the period. Finally, SG Americas Securities LLC increased its stake in AvePoint by 335.2% in the first quarter. SG Americas Securities LLC now owns 2,391,696 shares of the company’s stock valued at $22,745,000 after purchasing an additional 1,842,124 shares in the last quarter. Institutional investors own 44.49% of the company’s stock.

Key Headlines Impacting AvePoint

Here are the key news stories impacting AvePoint this week:

  • Positive Sentiment: BMO Capital Markets initiated coverage with an “outperform” rating and a $17.00 price target, implying meaningful upside from the reference price. The firm’s positive stance adds fresh institutional validation to AvePoint’s growth outlook. AvePoint Raised to Strong-Buy at BMO Capital Markets
  • Positive Sentiment: Analyst estimates compiled in a separate report put AvePoint’s average price target at $16.41, above the reference trading level. This suggests analysts see additional appreciation potential despite the stock’s gains over the past year. AvePoint Stock Has Average Target Price of $16.41 According to Analysts
  • Positive Sentiment: Recent bullish research highlights AvePoint’s positioning in agentic-AI governance, with AgentPulse reportedly supporting record net-new annual recurring revenue growth and larger customer deals. The company’s cash position, free-cash-flow yield and reported share repurchases also strengthen the investment case. AvePoint Growing Agentic AI Governance and Reasonable Valuations Should Drive Interest
  • Positive Sentiment: Another analysis rated AvePoint a buy, citing revenue and earnings growth, positive operating cash flow, global operations and limited leverage risk. Its role in AI, data protection, compliance and governance provides exposure to several expanding technology markets. AvePoint Rides AI-Driven Tailwind
  • Neutral Sentiment: Insider Brian Brown sold 28,894 shares for approximately $437,744, reducing his position by 7.92%. However, the transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, making it a limited bearish signal rather than clear evidence of deteriorating management confidence. SEC Insider Trading Filing

About AvePoint

(Get Free Report)

AvePoint, Inc (NASDAQ: AVPT) provides data-management, governance and protection solutions for organizations using cloud collaboration platforms. Its products are designed to help businesses migrate, manage, protect and optimize data across services such as Microsoft 365, SharePoint, Dynamics 365 and Salesforce.

The company’s offerings include cloud backup and recovery, data migration, records and information management, compliance, security and workspace governance. AvePoint delivers these capabilities through its cloud-based platform and related software, helping organizations manage data throughout its lifecycle while supporting collaboration and regulatory requirements.

Founded in 2001, AvePoint serves customers globally across a range of industries, including public-sector organizations, education, healthcare and commercial enterprises.

Recommended Stories

Analyst Recommendations for AvePoint (NASDAQ:AVPT)

Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.